Back

Functional improvement of non-infarct related coronary artery stenosis by extensive LDL-C reduction with a PCSK9 antibody: the FITTER trial, microvascular function analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering treatment: impact on the atherosclerotic plaque and outcomes Coronary Microcirculation and Collaterals ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Jonathan Los

Radboud University Nijmegen, Nijmegen (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Lower rate of ischemic events with PCSK9 inhibition in patients with atherosclerotic cardiovascular disease but without prior ischemic events
Professor D. Bhatt (New York City, US)
Abstract Slides Video
Presentation thumbnail
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
Doctor F. Marzano (Naples, IT)
Abstract Slides Video
Presentation thumbnail
PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis
Doctor P. Theofilis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Estimated impact of inclisiran treatment on hyperlipidemia prevalence and cardiovascular disease events in NHANES dataset
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
Doctor B. Kokina (Riga, LV)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering treatment: impact on the atherosclerotic plaque and outcomes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention
thumbnail
Congress Presentation
Invasive assessment of coronary microvascular dysfunction in patients with angina and unobstructed coronary arteries (ANOCA) - Comparison of Doppler- and Thermodilution derived measurements
thumbnail
Congress Presentation
Predictive value of the average three vessels microvascular resistance in patients with non-ST-segment elevation myocardial infarction after percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources